ARHGAP5, ARHGAP17 and ARHGAP24 promoted bladder cancer progression by establishing a tumor-promoting microenvironment or cellular mechanical property-mediated cell motility [21]. Here, ARHGAP17 is linked to urinary bladder carcinoma.